188 related articles for article (PubMed ID: 20713899)
1. Int6/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2alpha expression.
Chen L; Endler A; Uchida K; Horiguchi S; Morizane Y; Iijima O; Toi M; Shibasaki F
Circulation; 2010 Aug; 122(9):910-9. PubMed ID: 20713899
[TBL] [Abstract][Full Text] [Related]
2. Int6 silencing causes induction of angiogenic factors in neuronal cells via accumulation of hypoxia-inducible factor 2α and decreases brain damage in rats.
Miyashita R; Chen L; Oshiro H; Uchino H; Shibasaki F
Neurosci Lett; 2012 Oct; 528(1):83-8. PubMed ID: 22960363
[TBL] [Abstract][Full Text] [Related]
3. Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease.
Okamoto N; Tanaka A; Jung K; Karasawa K; Orito K; Matsuda A; Amagai Y; Oida K; Ohmori K; Matsuda H
Cardiovasc Res; 2011 Nov; 92(2):209-17. PubMed ID: 21771896
[TBL] [Abstract][Full Text] [Related]
4. Int6/eIF3e silenced HIF2α stabilization enhances migration and tube formation of HUVECs via IL-6 and IL-8 signaling.
Endler A; Chen L; Li Q; Uchida K; Hashimoto T; Lu L; Xu GT; Shibasaki F
Cytokine; 2013 Apr; 62(1):115-22. PubMed ID: 23478175
[TBL] [Abstract][Full Text] [Related]
5. Silencing of eIF3e promotes blood perfusion recovery after limb ischemia through stabilization of hypoxia-inducible factor 2α activity.
Hashimoto T; Chen L; Kimura H; Endler A; Koyama H; Miyata T; Shibasaki F; Watanabe T
J Vasc Surg; 2016 Jul; 64(1):219-226.e3. PubMed ID: 25758454
[TBL] [Abstract][Full Text] [Related]
6. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
DeNiro M; Alsmadi O; Al-Mohanna F
Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
[TBL] [Abstract][Full Text] [Related]
7. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice.
del Rey MJ; Izquierdo E; Caja S; Usategui A; Santiago B; Galindo M; Pablos JL
Arthritis Rheum; 2009 Oct; 60(10):2926-34. PubMed ID: 19790065
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs.
Jiang M; Wang B; Wang C; He B; Fan H; Guo TB; Shao Q; Gao L; Liu Y
J Cell Biochem; 2008 Jan; 103(1):321-34. PubMed ID: 17541946
[TBL] [Abstract][Full Text] [Related]
9. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
10. Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation.
Chen L; Uchida K; Endler A; Shibasaki F
J Biol Chem; 2007 Apr; 282(17):12707-16. PubMed ID: 17324924
[TBL] [Abstract][Full Text] [Related]
11. Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model.
Kamlah F; Eul BG; Li S; Lang N; Marsh LM; Seeger W; Grimminger F; Rose F; Hänze J
Cancer Gene Ther; 2009 Mar; 16(3):195-205. PubMed ID: 18818708
[TBL] [Abstract][Full Text] [Related]
12. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1alpha and -2alpha additively promote endothelial vasculogenic properties.
Ben-Shoshan J; Maysel-Auslender S; Luboshits G; Barshack I; Polak-Charcon S; Tzahor E; Keren G; George J
J Vasc Res; 2009; 46(4):299-310. PubMed ID: 19077391
[TBL] [Abstract][Full Text] [Related]
14. INT6/eIF3e represses E-cadherin expression through HIF2α in lung carcinoma A549 cells.
Gotoh-Saito S; Sadato D; Shibasaki F
Genes Cells; 2022 Dec; 27(12):689-705. PubMed ID: 36116043
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
Loinard C; Ginouvès A; Vilar J; Cochain C; Zouggari Y; Recalde A; Duriez M; Lévy BI; Pouysségur J; Berra E; Silvestre JS
Circulation; 2009 Jul; 120(1):50-9. PubMed ID: 19546390
[TBL] [Abstract][Full Text] [Related]
16. Essential role of PDGFRalpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRalpha during angiogenesis.
Tsutsumi N; Yonemitsu Y; Shikada Y; Onimaru M; Tanii M; Okano S; Kaneko K; Hasegawa M; Hashizume M; Maehara Y; Sueishi K
Circ Res; 2004 May; 94(9):1186-94. PubMed ID: 15059936
[TBL] [Abstract][Full Text] [Related]
17. Smooth muscle cell expression of a constitutive active form of human Rac 1 accelerates cutaneous wound repair.
Hassanain HH; Irshaid F; Wisel S; Sheridan J; Michler RE; Goldschmidt-Clermont PJ
Surgery; 2005 Jan; 137(1):92-101. PubMed ID: 15614286
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.
Diez H; Fischer A; Winkler A; Hu CJ; Hatzopoulos AK; Breier G; Gessler M
Exp Cell Res; 2007 Jan; 313(1):1-9. PubMed ID: 17045587
[TBL] [Abstract][Full Text] [Related]
19. Int6/eIF3e Silencing Promotes Placenta Angiogenesis in a Rat Model of Pre-eclampsia.
Li Q; Yao B; Endler A; Chen L; Shibasaki F; Cheng H
Sci Rep; 2018 Jun; 8(1):8944. PubMed ID: 29895936
[TBL] [Abstract][Full Text] [Related]
20. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression.
Sato F; Bhawal UK; Kawamoto T; Fujimoto K; Imaizumi T; Imanaka T; Kondo J; Koyanagi S; Noshiro M; Yoshida H; Kusumi T; Kato Y; Kijima H
Genes Cells; 2008 Feb; 13(2):131-44. PubMed ID: 18233956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
